Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyspnea possibly associated with controlled-release morphine sulfate tablets.

H D Kerr1

  • 1Medical College of Wisconsin, Milwaukee.

Drug Intelligence & Clinical Pharmacy
|May 1, 1988
PubMed
Summary

Controlled-release morphine sulfate tablets, used for chronic pain, may cause dyspnea (difficulty breathing). Stopping the medication resolved the symptom, highlighting potential respiratory risks, especially in elderly patients.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fractures of the femoral neck following pelvic irradiation.

The American journal of roentgenology and radium therapy·2010
Same author

Diagnosis and treatment of cancer of the uterus.

American practitioner and digest of treatment·2010
Same author

A quadriplegic man with hypothermia and thrombocytopenia.

WMJ : official publication of the State Medical Society of Wisconsin·1999
Same author

Ureteral stent displacement associated with deep massage.

WMJ : official publication of the State Medical Society of Wisconsin·1998
Same author

Status epilepticus after cranial CT with contrast media.

WMJ : official publication of the State Medical Society of Wisconsin·1997
Same author

Doxapram in hypercapnic chronic obstructive pulmonary disease with respiratory failure.

The Journal of emergency medicine·1997

Area of Science:

  • Pharmacology
  • Oncology
  • Geriatrics

Background:

  • Controlled-release morphine sulfate is a novel oral analgesic for severe chronic pain.
  • Cancer-related pain, particularly bone metastases, is a common indication.